CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 101 filers reported holding CARA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $7,009,000 | +52.3% | 754,488 | +36.9% | 0.00% | 0.0% |
| Q3 2016 | $4,602,000 | +129.5% | 551,181 | +32.2% | 0.00% | – |
| Q2 2016 | $2,005,000 | -22.5% | 416,785 | +0.2% | 0.00% | – |
| Q1 2016 | $2,588,000 | -63.6% | 416,111 | -1.2% | 0.00% | -100.0% |
| Q4 2015 | $7,102,000 | +35.7% | 421,247 | +15.0% | 0.00% | 0.0% |
| Q3 2015 | $5,233,000 | +316.0% | 366,233 | +253.6% | 0.00% | – |
| Q2 2015 | $1,258,000 | +185.3% | 103,567 | +136.3% | 0.00% | – |
| Q1 2015 | $441,000 | +0.9% | 43,835 | +0.0% | 0.00% | – |
| Q4 2014 | $437,000 | +16.2% | 43,820 | -2.1% | 0.00% | – |
| Q3 2014 | $376,000 | -55.4% | 44,764 | -9.6% | 0.00% | – |
| Q2 2014 | $843,000 | -10.4% | 49,515 | -2.1% | 0.00% | – |
| Q1 2014 | $941,000 | – | 50,566 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 3,568,057 | $70,005,000 | 74.08% |
| Chescapmanager LLC | 1,203,055 | $23,604,000 | 2.80% |
| Mesirow Financial Investment Management, Inc. | 29,821 | $585,000 | 2.32% |
| DAFNA Capital Management LLC | 143,611 | $2,818,000 | 1.22% |
| Opaleye Management Inc. | 200,000 | $3,924,000 | 1.09% |
| SPHERA FUNDS MANAGEMENT LTD. | 303,930 | $5,963,000 | 0.54% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 852,892 | $16,734,000 | 0.29% |
| DLD Asset Management, LP | 352,700 | $6,927,000 | 0.26% |
| SHANDA ASSET MANAGEMENT HOLDINGS Ltd | 54,984 | $1,079,000 | 0.18% |
| B. Riley Wealth Management, Inc. | 33,755 | $662,000 | 0.12% |